Search details
1.
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients.
Br J Cancer
; 130(11): 1866-1874, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38532102
2.
Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma.
Oncologist
; 2024 May 18.
Article
in English
| MEDLINE | ID: mdl-38761384
3.
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network.
J Eur Acad Dermatol Venereol
; 2024 Jun 12.
Article
in English
| MEDLINE | ID: mdl-38864258
4.
Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East.
Int J Cancer
; 149(11): 1926-1934, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34310716
5.
Ocular Safety Profile of BRAF and MEK Inhibitors: Data from the World Health Organization Pharmacovigilance Database.
Ophthalmology
; 128(12): 1748-1755, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34000304
6.
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.
J Transl Med
; 17(1): 357, 2019 11 04.
Article
in English
| MEDLINE | ID: mdl-31684954
7.
Drug-induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome.
Am J Hematol
; 99(7): 1427-1430, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38642007
8.
Pembrolizumab for Unresectable or Metastatic Melanoma in Patients Older than 85 Years of Age.
Dermatology
; 235(3): 219-224, 2019.
Article
in English
| MEDLINE | ID: mdl-30721908
9.
Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients.
Invest New Drugs
; 35(6): 842-847, 2017 12.
Article
in English
| MEDLINE | ID: mdl-28569347
10.
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.
Invest New Drugs
; 35(4): 436-441, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28396974
11.
Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patients.
Pharmacol Res
; 113(Pt A): 709-718, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27378568
12.
Complete Penetrance and Absence of Intrafamilial Variability in a Large Family with Hereditary Leiomyomatosis and Renal Cell Carcinoma.
Dermatology
; 232(3): 293-7, 2016.
Article
in English
| MEDLINE | ID: mdl-27161211
13.
Sarcoidosis in Patients Treated with Vemurafenib for Metastatic Melanoma: A Paradoxical Autoimmune Activation.
Dermatology
; 231(4): 378-84, 2015.
Article
in English
| MEDLINE | ID: mdl-26452227
14.
Dramatic but suspensive effect of interleukin-1 inhibitors for persistent urticarial vasculitis: a French multicentre retrospective study.
Ann Rheum Dis
; 78(10): 1446-1448, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31189550
15.
Unresectable Non-metastatic Primary Melanoma: Complete Remission Following Treatment with Anti-Programmed-cell-death-receptor 1.
Acta Derm Venereol
; 99(1): 107-108, 2019 Jan 01.
Article
in English
| MEDLINE | ID: mdl-30176045
16.
Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients.
Eur J Dermatol
; 33(6): 680-685, 2023 Dec 01.
Article
in English
| MEDLINE | ID: mdl-38465550
17.
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity.
Brain Commun
; 5(3): fcad169, 2023.
Article
in English
| MEDLINE | ID: mdl-37389303
18.
Erratum to: Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.
Invest New Drugs
; 35(4): 537, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28597150
19.
Primary Cutaneous Mucinous Carcinoma Monitoring: A Role for CA15.3 and CEA?
Case Rep Oncol
; 15(3): 1114-1119, 2022.
Article
in English
| MEDLINE | ID: mdl-36655184
20.
Locally Advanced Unresectable Vaginal Melanoma: Response With Anti-Programmed Death Receptor 1.
J Low Genit Tract Dis
; 20(1): e4-5, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26704337